Citation: | LIU Yawen, ZHAO Qun, ZHENG Haowen, KONG Xiang, SONG Jingzhe. Expressions and significance of CXC chemokine ligand 12 and human cartilage glycoprotein-39 in serum and placental tissues of patients with preeclampsia[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 16-19. DOI: 10.7619/jcmp.20220392 |
[1] |
AO D, LID J, LIM Q. CXCL12 in normal and pathological pregnancies: a review[J]. Am J Reprod Immunol, 2020, 84(3): e13280.
|
[2] |
DARAKHSHAN S, HASSANSHAHI G, MOFIDIFAR Z, et al. CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates[J]. Pregnancy Hypertens, 2019, 17: 36-42. doi: 10.1016/j.preghy.2019.05.001
|
[3] |
ST∅DLE G S, SILVAGB, TANGERÅSLH, et al. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts[J]. Clin Exp Immunol, 2018, 193(1): 84-94. doi: 10.1111/cei.13130
|
[4] |
ANEMAN I, PIENAARD, SUVAKOV S, et al. Mechanisms of key innate immune cells in early- and late-onset preeclampsia[J]. FrontImmunol, 2020, 11: 1864. https://pubmed.ncbi.nlm.nih.gov/33013837/
|
[5] |
BURTONG J, REDMANC W, ROBERTSJ M, et al. Pre-eclampsia: pathophysiology and clinical implications[J]. BMJ, 2019, 366: l2381. https://www.bmj.com/content/366/bmj.l2381
|
[6] |
GYBEL-BRASKD, H∅GDALL E, JOHANSEN J, et al. Serum YKL-40 and uterine artery Doppler-a prospective cohort study, with focus on preeclampsia and small-for-gestational-age[J]. Acta ObstetGynecolScand, 2014, 93(8): 817-824. https://www.ncbi.nlm.nih.gov/pubmed/24861484/
|
[7] |
谢幸. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 21-28.
|
[8] |
LEIG Q, WUZ Y, JIANGW B, et al. Effect of CXCL12/CXCR4 on migration of decidua-derived mesenchymal stem cells from pregnancies with preeclampsia[J]. Am J Reproductive Immunol, 2019, 82(5): e13180. https://pubmed.ncbi.nlm.nih.gov/31397035/
|
[9] |
WANG L, LI X Y, ZHAO Y L, et al. Insights into the mechanism of CXCL12-mediated signaling in trophoblast functions and placental angiogenesis[J]. Acta BiochimBiophys Sin, 2015, 47(9): 663-672. https://pubmed.ncbi.nlm.nih.gov/26188201/
|
[10] |
XU J E, CHEN K, LI A Q, et al. Polymorphism-801G/A in the 3′-untranslated region of CXCL12 is not associated with preeclampsia in Chinese Han population[J]. Clin Exp Hypertens, 2017, 39(1): 23-28. doi: 10.1080/10641963.2016.1200598
|
[11] |
HWANGH S, KWONH S, SOHNI S, et al. Increased CXCL12 expression in the placentae of women with pre-eclampsia[J]. Eur J ObstetGynecolReprod Biol, 2012, 160(2): 137-141. https://www.ncbi.nlm.nih.gov/pubmed/22071114
|
[12] |
LU J, ZHOUW H, REN L, et al. CXCR4, CXCR7, and CXCL12 are associated with trophoblastic cells apoptosis and linked to pathophysiology of severe preeclampsia[J]. Exp Mol Pathol, 2016, 100(1): 184-191. doi: 10.1016/j.yexmp.2015.12.013
|
[13] |
CHAU K, XU B, HENNESSY A, et al. Effect of placental growth factor on trophoblast-endothelial cell interactions in vitro[J]. Reprod Sci, 2020, 27(6): 1285-1292. doi: 10.1007/s43032-019-00103-7
|
[14] |
SCHANZ A, WINNV D, FISHERS J, et al. Pre-eclampsia is associated with elevated CXCL12 levels in placental syncytiotrophoblasts and maternal blood[J]. Eur J ObstetGynecolReprod Biol, 2011, 157(1): 32-37. https://pubmed.ncbi.nlm.nih.gov/21450389/
|
[15] |
LU H, JINL P, HUANGH L, et al. Trophoblast-derived CXCL12 promotes CD56 bright CD82-CD29+NK cell enrichment in the decidua[J]. Am J Reprod Immunol, 2020, 83(2): 2020Feb; 83(2).
|
[16] |
AMINZADEH F, GHORASHI Z, NABATI S, et al. Differential expression of CXC chemokines CXCL10 and CXCL12 in term and pre-term neonates and their mothers[J]. Am J Reprod Immunol, 2012, 68(4): 338-344. doi: 10.1111/j.1600-0897.2012.01167.x
|
[17] |
KHANDANYB K, HASSANSHAHI G, KHORRAMDELAZAD H, et al. Evaluation of circulating concentrations of CXCL1 (Gro-α), CXCL10 (IP-10) and CXCL12 (SDF-1) in ALL patients prior and post bone marrow transplantation[J]. Pathol Res Pract, 2012, 208(10): 615-619. doi: 10.1016/j.prp.2012.06.009
|
[18] |
NIRUPAMA R, DIVYASHREE S, JANHAVI P, et al. Preeclampsia: pathophysiology and management[J]. J GynecolObstet Hum Reprod, 2021, 50(2): 101975.
|
[19] |
CORNELIUSD C, COTTRELL J, AMARALLM, et al. Inflammatory mediators: a causal link to hypertension during preeclampsia[J]. BrJPharmacol, 2019, 176(12): 1914-1921.
|
[20] |
CORNELIUS D C. Preeclampsia: from inflammation to immunoregulation[J]. Clin Med Insights Blood Disord, 2018, 11: 1179545X17752325.
|
[21] |
KUCUR M, TUTEN A, ONCUL M, et al. Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia[J]. Hypertens Pregnancy, 2014, 33(4): 467-475. doi: 10.3109/10641955.2014.944709
|
[22] |
DENG Y J, LI G Y, CHANG D, et al. YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases[J]. Clin Chimica Acta, 2020, 511: 40-46. doi: 10.1016/j.cca.2020.09.035
|
[23] |
PEREZM F, ATUEGWUN C, MORTENSENE M, et al. The inflammatory biomarker YKL-40 is elevated in the serum, but not the sputum, of E-cigarette users[J]. Exp Lung Res, 2021, 47(2): 55-66. doi: 10.1080/01902148.2020.1847216
|
[24] |
YAO Z, BOYCE B F, KORDULA T, et al. RelB/p50 complexes regulate cytokineinduced YKL-40 expression[J]. J Immunol, 2015, 194(6): 2862-2870. doi: 10.4049/jimmunol.1400874
|
[25] |
TANG H, SUN Y, SHI Z Q, et al. YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration[J]. J Immunol, 2013, 190(1): 438-446. doi: 10.4049/jimmunol.1201827
|
[26] |
LIMJCW, GOHFY, SAGINEEDUS R, et al. A semisynthetic diterpenoid lactone inhibits NF-κB signalling to ameliorate inflammation and airway hyperresponsiveness in a mouse asthma model[J]. Toxicol Appl Pharmacol, 2016, 302: 10-22. doi: 10.1016/j.taap.2016.04.004
|
1. |
吴晓文,李军,尧国胜,韦凌云,黄高. 不同人工肝治疗在急性肝衰竭治疗中的临床疗效对比研究. 智慧健康. 2024(25): 96-98+101 .
![]() |